Raymond Kelly — SPARQNOW

At-a-Glance

Chief Regulatory Officer at Arazy Group Consultants Inc.
Secured over 140 FDA approvals, including 510(k), de novo, AI/ML devices, IVD, and implants.
Expert in U.S. FDA and Health Canada submissions (510(k), de novo, IND, IDE, HUD, HDE).
Contributor and early adopter of AI-based regulatory affairs platforms like Licensale®, Regislate™, and Arazy AI™.

Biography

Raymond Kelly serves as the Chief Regulatory Officer at Arazy Group Consultants Inc., bringing over two decades of experience as a global regulatory affairs strategist in the MedTech sector. He specializes in navigating complex regulatory landscapes to bring advanced medical devices to global markets.

Kelly's expertise includes U.S.